In vitro experiments demonstrated that exogenous HMGB1 increased the expression of RAGE and TLR4 in ECs, further confirming that RAGE is the primary receptor for HMGB1 in tumor ECs (153). The gene discussed is HMGB1; the disease is neoplasm.